A Simplified Approach to Pulmonary Vein Visualization during Cryoballoon Ablation of Atrial Fibrillation
- PMID: 36556902
- PMCID: PMC9781762
- DOI: 10.3390/medicina58121700
A Simplified Approach to Pulmonary Vein Visualization during Cryoballoon Ablation of Atrial Fibrillation
Abstract
Background and Objectives: Selective pulmonary vein (PV) angiography has been established as the gold standard for PV visualization in cryoballoon (CB)-based pulmonary vein isolation (PVI). We sought to simplify this approach to reduce procedural complexity and radiation exposure. Materials and Methods: Patients with paroxysmal and recently diagnosed persistent AF undergoing CB-based PVI from January 2015 to December 2017 were retrospectively analyzed. Patients underwent either selective PV angiography or conventional left atrial (LA) angiography for PV visualization. Results: A total of 336 patients were analyzed. A total of 87 patients (26%) received PV angiography and 249 (74%) LA angiography. LA angiography required fewer cine-sequences for PV visualization, translating into a significant reduction in procedure duration, fluoroscopy time and dose area product. Additionally, less contrast medium was utilized. PV occlusion by the CB, CB temperature and time to isolation showed no significant differences. The number of CB applications and total application time (LA angiography: 1.4 ± 0.02 vs. PV Angiography: 1.6 ± 0.05; p < 0.0001; LA angiography: 297.9 ± 4.62 vs. PV-Angiography: 348.9 ± 11.03; p < 0.001, respectively) per vein were slightly but significantly higher in the PV angiography group. We observed no difference in late AF recurrence (24.7% LA angiography vs. 21.3% PV angiography; p = 0.2657). Conclusions: A simplified protocol, using LA angiography for PV visualization, entails a reduction in procedure time and radiation exposure while equally maintaining procedural efficiency and safety in both groups.
Keywords: angiography; atrial fibrillation; cryoballoon; pulmonary vein isolation.
Conflict of interest statement
N.G. reports grants from Boston Scientific, grants from Medtronic and support from Bayer Vital outside the submitted work. C.M. reports grants and/or personal fees from Abbott, Biosense Webbster, Biotronik, Boehringer Ingelheim, Boston Scientific, Bristol Myers Squibb, Daiichi Sankyo and Medtronic outside the submitted work. S.W. reports grants and personal fees from Abbott, Boston Scientific and Medtronic, and personal fees from Abbott, Boehringer Ingelheim, Bristol Myers Squibb, Bayer Vital, Acutus and Daiichi Sankyo, outside the submitted work. C.E. reports grants and/or personal fees from Abbott, Biosense Webbster, Biotronik, Boehringer Ingelheim, Boston Scientific, Bristol Myers Squibb, Daiichi Sankyo and Medtronic outside the submitted work. The remaining authors declare no conflict of interest in relation to this article.
Figures




Similar articles
-
Reducing radiation exposure in second-generation cryoballoon ablation without compromising clinical outcome.J Interv Card Electrophysiol. 2021 Mar;60(2):287-294. doi: 10.1007/s10840-020-00737-7. Epub 2020 Apr 13. J Interv Card Electrophysiol. 2021. PMID: 32285243 Free PMC article.
-
Comparison of advanced generation cryoballoon ablation and ablation index-guided pulmonary vein isolation with non-pulmonary vein trigger induction test and additional ablation in paroxysmal atrial fibrillation.J Interv Card Electrophysiol. 2023 Oct;66(7):1571-1580. doi: 10.1007/s10840-022-01459-8. Epub 2022 Dec 28. J Interv Card Electrophysiol. 2023. PMID: 36575227
-
Is the time of atrial fibrillation recurrence after cryoballoon ablation of paroxysmal atrial fibrillation influenced by the pattern of PV reconnections?J Interv Card Electrophysiol. 2021 Mar;60(2):321-327. doi: 10.1007/s10840-020-00804-z. Epub 2020 Jul 3. J Interv Card Electrophysiol. 2021. PMID: 32621212
-
Additional cryoapplications at the pulmonary vein antrum using a 28-mm second-generation cryoballoon: a pilot study of extra-pulmonary vein ablation.Heart Vessels. 2018 Sep;33(9):1052-1059. doi: 10.1007/s00380-018-1142-4. Epub 2018 Feb 20. Heart Vessels. 2018. PMID: 29464341
-
The impact of left atrium size on selection of the pulmonary vein isolation method for atrial fibrillation: Cryoballoon or radiofrequency catheter ablation.Am Heart J. 2021 Jan;231:82-92. doi: 10.1016/j.ahj.2020.10.061. Epub 2020 Oct 22. Am Heart J. 2021. PMID: 33098808
References
-
- Kuck K., Brugada J., Schlüter M., Braegelmann K.M., Kueffer F.J., Chun K.R.J., Albenque J., Tondo C., Calkins H., Metzner A., et al. The FIRE AND ICE Trial: What We Know, What We Can Still Learn, and What We Need to Address in the Future. J. Am. Heart Assoc. 2018;7:e010777. doi: 10.1161/JAHA.118.010777. - DOI - PMC - PubMed
-
- Chun K.R.J., Brugada J., Elvan A., Gellér L., Busch M., Barrera A., Schilling R.J., Reynolds M.R., Hokanson R.B., Holbrook R., et al. The Impact of Cryoballoon Versus Radiofrequency Ablation for Paroxysmal Atrial Fibrillation on Healthcare Utilization and Costs: An Economic Analysis from the FIRE AND ICE Trial. J. Am. Heart Assoc. 2017;6:e006043. doi: 10.1161/JAHA.117.006043. - DOI - PMC - PubMed
-
- Su W.W., Reddy V.Y., Bhasin K., Champagne J., Sangrigoli R.M., Braegelmann K.M., Kueffer F.J., Novak P., Gupta S.K., Yamane T., et al. Cryoballoon ablation of pulmonary veins for persistent atrial fibrillation: Results from the multicenter STOP Persistent AF trial. Heart Rhythm. 2020;17:1841–1847. doi: 10.1016/j.hrthm.2020.06.020. - DOI - PubMed
-
- Kautzner J., Micochova H., Peichl P. Anatomy of the Left Atrium and Pulmonary Veins- Lessons Learned from Novel Imaging Techniques. Eur. Cardiovasc. Dis. 2006;2:89–90.
-
- Vasamreddy C.R., Jayam V., Lickfett L., Nasir K., Bradley D.J., Eldadah Z., Dickfeld T., Donahue K., Halperin H.R., Berger R., et al. Technique and Results of Pulmonary Vein Angiography in Patients Undergoing Catheter Ablation of Atrial Fibrillation. J. Cardiovasc. Electrophysiol. 2004;15:21–26. doi: 10.1046/j.1540-8167.2004.03352.x. - DOI - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical